Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Flanagan, L. Glackin, D. Slattery (Dublin, Ireland). Improved turn around time for molecular genetic analysis for cystic fibrosis: The Irish experience. Eur Respir J 2011; 38: Suppl. 55, 4304

Member's Comments

No comment yet.

Related content which might interest you: A contemporary survival analysis of individuals with cystic fibrosis: a cohort study Source: Eur Respir J 2015; 45: 670-679 Year: 2015 Assessment of NuvoAir platform use on clinical outcomes in adults with cystic fibrosis: a first Italian experience Source: Virtual Congress 2021 – Cystic fibrosis Year: 2021 The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis? Source: Eur Respir J 2016; 48: 1271-1273 Year: 2016 Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis Source: Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017 Year: 2017 A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases Year: 2021 Assessment of regional resistance distribution using computational fluid dynamics in cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007 Leveraging early markers of cystic fibrosis structural lung disease to improve outcomes Source: Eur Respir J, 55 (4) 2000105; 10.1183/13993003.00105-2020 Year: 2020 Accelerated variant of idiopathic pulmonary fibrosis: clinical and molecular behaviour Source: Eur Respir J 2007; 30: Suppl. 51, 488s Year: 2007 Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 The German cystic fibrosis quality assurance project: clinical features in children and adults Source: Eur Respir J 2001; 17: 1187-1194 Year: 2001 Inflammation, age and changing microbiology: the search for causation in the cystic fibrosis airways Source: Eur Respir J, 50 (5) 1701935; 10.1183/13993003.01935-2017 Year: 2017 Is ceramide the missing link between the molecular defect and the lung disease of cystic fibrosis? Source: Breathe 2008; 4: 365 Year: 2008 Genetic characterization of cystic fibrosis patients in Portugal Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children Year: 2013 CF-ABLE-UK score: Modification and validation of a clinical prediction rule for prognosis in cystic fibrosis on data from UK CF registry Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 A model for active and healthy ageing with a rare genetic disease: cystic fibrosis Source: Eur Respir J 2016; 47: 714-719 Year: 2016 Impact of a high emergency lung transplantation programme for cystic fibrosis in France: insight from a comparison with Canada Source: Eur Respir J, 59 (1) 2100014; 10.1183/13993003.00014-2021 Year: 2022